Nextrials, Inc. will again participate in the annual IHE North America Connectathon sponsored by IHE (Integrating the Healthcare Enterprise), to be held January 9-14 at the Hyatt Regency Chicago. This is the fourth consecutive year for Nextrials’ participation in the event, where it will showcase the flexibility of Prism®, its clinical trial management platform; Prism is one of the clinical research industry’s few electronic data capture (EDC) platforms fully integrated with platforms used for electronic health records (EHR) by the healthcare industry. During the Connectathon demonstration on Saturday, January 14, Prism will facilitate live data streaming between multiple EHR vendors and data recipients.
Nextrials is one of just two EDC solution providers participating in the Connectathon, the healthcare IT industry’s only large-scale interoperability testing event dedicated to establishing standards that address specific clinical needs in support of optimal patient care. The event is an important qualifier for the HIMSS12 Interoperability Showcase™, being held at the Venetian-Sands Expo Convention Center in Las Vegas February 20-24, 2012.
Nextrials’ Prism melds clinical trial management functionality with EDC in a single, integrated package. By receiving a constant flow of data, Prism enables sponsors and sites to fully utilize real-time integration of disparate information and data sources, such as a hospital’s EHR or patient records, to better provide a continuum of care for patients enrolled in clinical trials.
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
FDA-Approved Gene Therapy Beqvez Shows Sustained Efficacy, Safety in Long-Term Hemophilia B Trial
April 17th 2025Beqvez (fidanacogene elaparvovec), an FDA-approved one-time gene therapy for hemophilia B, demonstrated sustained factor IX expression, low bleeding rates, and a favorable safety profile over long-term follow-up.